The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …

Breast cancer (BRCA) is the most leading cause of cancer worldwide. It is a heterogeneous
disease with at least five molecular subtypes including luminal A, luminal B, basal-like …

Bladder cancer (BC), a malignancy originating in the epithelial tissue in the inner wall of the
bladder, is a common urological cancer type. BC spreads through 3 main pathways: direct …

Bladder cancer is one of the most common malignant tumors worldwide. Accordingly, its
incidence and mortality are high. One of the characteristics of cancer is genomic instability …

Heat shock proteins are highly expressed in various cancers and exert critical functions in
tumor progression. However, their expression patterns and functions in lung …

Cuproptosis is a new form of cell death, the second form of metal ion-induced cell death
defined after ferroptosis. Recently, cuproptosis has been suggested to be associated with …

Bladder cancer (BLCA) is the 10th most common form of cancer worldwide. Currently, the
response rate of BLCA patients to novel immunotherapy and immune checkpoint inhibitor …

Bladder cancer (BLCA) is one of the highly heterogeneous disorders accompanied by a
poor prognosis. The present study aimed to construct a model based on pyroptosis-related …

Bladder cancer (BC) is featured as the second most common malignancy of the urinary tract
worldwide with few treatments leading to high incidence and mortality. It stayed a virtually …

This study constructed a novel cuproptosis-related lncRNAs signature to predict the
prognosis of BLCA patients. The Cancer Genome Atlas (TCGA) database was used to …